1-anilino-8-naphthalenesulfonate has been researched along with Atrophy in 14 studies
1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
Excerpt | Relevance | Reference |
---|---|---|
"The results of the present study suggest that camostat greatly inhibits pancreatic inflammation and prevents and reverses fibrosis and atrophy of the pancreas in the genetically obese and CCK-1 receptor-deficient OLETF rats." | 7.73 | Preventive and therapeutic effects of the protease inhibitor camostat on pancreatic fibrosis and atrophy in CCK-1 receptor-deficient rats. ( Jia, D; Otsuki, M; Taguchi, M, 2005) |
"The results of the present study suggest that camostat greatly inhibits pancreatic inflammation and prevents and reverses fibrosis and atrophy of the pancreas in the genetically obese and CCK-1 receptor-deficient OLETF rats." | 3.73 | Preventive and therapeutic effects of the protease inhibitor camostat on pancreatic fibrosis and atrophy in CCK-1 receptor-deficient rats. ( Jia, D; Otsuki, M; Taguchi, M, 2005) |
"Distal myopathy is a group of heterogeneous disorders affecting predominantly distal muscles usually appearing from young to late adulthood with very rare cardiac complications." | 1.35 | Distal lipid storage myopathy due to PNPLA2 mutation. ( Hayashi, YK; Malicdan, MC; Nishino, I; Noguchi, S; Nomura, K; Nonaka, I; Ohji, S; Ohkuma, A; Sugie, H, 2008) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (57.14) | 18.7374 |
1990's | 1 (7.14) | 18.2507 |
2000's | 3 (21.43) | 29.6817 |
2010's | 2 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ohkuma, A | 1 |
Nonaka, I | 1 |
Malicdan, MC | 1 |
Noguchi, S | 1 |
Ohji, S | 1 |
Nomura, K | 1 |
Sugie, H | 1 |
Hayashi, YK | 1 |
Nishino, I | 1 |
Freitag, TL | 1 |
Cham, C | 1 |
Sung, HH | 1 |
Beilhack, GF | 1 |
Durinovic-Belló, I | 1 |
Patel, SD | 1 |
Bronson, RT | 1 |
Schuppan, D | 1 |
Sønderstrup, G | 1 |
Baumler, MD | 2 |
Koopmann, MC | 1 |
Thomas, DD | 1 |
Ney, DM | 2 |
Groblewski, GE | 2 |
BALLINGER, WF | 1 |
IIDA, J | 1 |
APONTE, GE | 1 |
WIRTS, CW | 1 |
GOLDSTEIN, F | 1 |
VALDIVIESO, VD | 1 |
SCHWABE, AD | 1 |
Jia, D | 1 |
Taguchi, M | 1 |
Otsuki, M | 1 |
Nelson, DW | 1 |
Korot'ko, GF | 1 |
Vepritskaia, EA | 1 |
Putzke, HP | 1 |
Jonas, L | 1 |
Arendt, R | 1 |
Siegmund, E | 1 |
Dummler, W | 1 |
Vulinec, M | 1 |
Medvedev, MA | 1 |
Vasil'ev, VN | 1 |
Afanas'eva, AN | 1 |
Grabovskaia, EA | 1 |
Gorskiĭ, AA | 1 |
Potekhin, AV | 1 |
Valdivieso, V | 1 |
Thompson, JN | 1 |
Scott, ML | 1 |
Kluge, H | 1 |
Wieczorek, V | 1 |
1 review available for 1-anilino-8-naphthalenesulfonate and Atrophy
Article | Year |
---|---|
[New facts on the diagnosis of exocrine pancreatic insufficiency in carnivora].
Topics: 4-Aminobenzoic Acid; Alkaline Phosphatase; Amylases; Animals; Atrophy; Carnivora; Chymotrypsin; Dog | 1980 |
13 other studies available for 1-anilino-8-naphthalenesulfonate and Atrophy
Article | Year |
---|---|
Distal lipid storage myopathy due to PNPLA2 mutation.
Topics: Adult; Atrophy; Cardiomyopathy, Dilated; Distal Myopathies; Hand; Humans; Leg; Lipase; Lipid Metabol | 2008 |
Human risk allele HLA-DRB1*0405 predisposes class II transgenic Ab0 NOD mice to autoimmune pancreatitis.
Topics: Adoptive Transfer; Animals; Atrophy; Autoimmune Diseases; Female; Genes, MHC Class II; HLA-DR Antige | 2010 |
Intravenous or luminal amino acids are insufficient to maintain pancreatic growth and digestive enzyme expression in the absence of intact dietary protein.
Topics: Adaptation, Physiological; Administration, Oral; Amino Acids; Amylases; Animals; Atrophy; Chymotryps | 2010 |
STRUCTURE AND FUNCTION OF THE CANINE SMALL INTESTINE FOLLOWING TOTAL ABDOMINAL VAGOTOMY.
Topics: Amylases; Anatomy; Animals; Atrophy; Denervation; Dogs; Duodenum; Histology; Intestinal Diseases; In | 1964 |
FACTORS INFLUENCING THE ABSORPTION OF A MEDIUM CHAIN TRIGLYCERIDE.II. THE ROLE OF PANCREATIC JUICE IN THE INTRALUMINAL PHASE OF ABSORPTION.
Topics: Atrophy; Bicarbonates; Carbon Dioxide; Carbon Isotopes; Glycerides; Intestinal Absorption; Jejunum; | 1965 |
Preventive and therapeutic effects of the protease inhibitor camostat on pancreatic fibrosis and atrophy in CCK-1 receptor-deficient rats.
Topics: Actins; Amylases; Animals; Atrophy; Eating; Esters; Fibrosis; Gabexate; Guanidines; Interleukin-6; L | 2005 |
Loss of exocrine pancreatic stimulation during parenteral feeding suppresses digestive enzyme expression and induces Hsp70 expression.
Topics: Amylases; Animals; Apoptosis; Atrophy; Body Weight; Chaperonin 60; Enzyme Precursors; Glucagon-Like | 2007 |
[Mechanisms stabilizing the concentration of intestinal gland hydrolases in peripheral blood].
Topics: Amylases; Anesthesia, General; Animals; Atrophy; Dogs; Duodenum; Hydrolases; Lipase; Pancreatic Dise | 1981 |
[Pancreatic findings after ductal occlusion in rats. A histological and biochemical study].
Topics: Amylases; Animals; Atrophy; Diatrizoate; Drug Combinations; Fatty Acids; Lipase; Male; Pancreas; Pan | 1982 |
[Hypotrypsinemia as a possible factor in the activation of motor function of the duodenum in pancreatic atrophy in rats].
Topics: Amylases; Animals; Atrophy; Duodenum; Electromyography; Gastrointestinal Motility; Lipase; Male; Pan | 1992 |
Absorption of medium-chain triglycerides in animals with pancreatic atrophy.
Topics: Animals; Atrophy; Carbon Isotopes; Cecum; Chemical Phenomena; Chemistry; Chromatography, Thin Layer; | 1972 |
Impaired lipid and vitamin E absorption related to atrophy of the pancreas in selenium-deficient chicks.
Topics: Amino Acids; Animals; Aspartate Aminotransferases; Atrophy; Carbon Isotopes; Chickens; Chymotrypsin; | 1970 |
[Lipase activities in the cerebrospinal fluid].
Topics: Adult; Atrophy; Brain Diseases; Brain Neoplasms; Central Nervous System Diseases; Clinical Enzyme Te | 1968 |